Unraveling the intricacies of small cell lung cancer: FAK splicing variants as a new feature and therapeutic vulnerability of small cell lung cancer

References

[1] Sung H , Ferlay J , Siegel RL , Laversanne M , Soerjomataram I , Jemal A , Bray F . Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71(3): 209–249

[2] Wang GZ , Wang Z , Bai SH , Tan Y , Zhong WZ , Sun GG , Liu YT , Pan B , Huang C , Wang D , Sun BB , Chen DN , Zhang B , Zhou YC , Li S , Zhang XW , Han SC , Yang FY , Shi XY , Jie XL , Shen YK , Liang LJ , Wen ZS , Zhang L , Li MK , Wang N , Liu J , Dong Y , Wang ML , Wang Y , Wang CL , Xie DW , Han ZG , Ying JM , Chen C , Huang YC , Ji HB , Zhang YY , Yu Y , Zhou GB . Characterization of the extrinsic and intrinsic signatures and therapeutic vulnerability of small cell lung cancers. Signal Transduct Target Ther 2025; 10(1): 290

[3] George J , Lim JS , Jang SJ , Cun Y , Ozretić L , Kong G , Leenders F , Lu X , Fernández-Cuesta L , Bosco G , Müller C , Dahmen I , Jahchan NS , Park KS , Yang D , Karnezis AN , Vaka D , Torres A , Wang MS , Korbel JO , Menon R , Chun SM , Kim D , Wilkerson M , Hayes N , Engelmann D , Pützer B , Bos M , Michels S , Vlasic I , Seidel D , Pinther B , Schaub P , Becker C , Altmüller J , Yokota J , Kohno T , Iwakawa R , Tsuta K , Noguchi M , Muley T , Hoffmann H , Schnabel PA , Petersen I , Chen Y , Soltermann A , Tischler V , Choi C , Kim YH , Massion PP , Zou Y , Jovanovic D , Kontic M , Wright GM , Russell PA , Solomon B , Koch I , Lindner M , Muscarella LA , la Torre A , Field JK , Jakopovic M , Knezevic J , Castaños-Vélez E , Roz L , Pastorino U , Brustugun OT , Lund-Iversen M , Thunnissen E , Köhler J , Schuler M , Botling J , Sandelin M , Sanchez-Cespedes M , Salvesen HB , Achter V , Lang U , Bogus M , Schneider PM , Zander T , Ansén S , Hallek M , Wolf J , Vingron M , Yatabe Y , Travis WD , Nürnberg P , Reinhardt C , Perner S , Heukamp L , Büttner R , Haas SA , Brambilla E , Peifer M , Sage J , Thomas RK . Comprehensive genomic profiles of small cell lung cancer. Nature 2015; 524(7563): 47–53

[4] Stewart CA , Gay CM , Xi Y , Sivajothi S , Sivakamasundari V , Fujimoto J , Bolisetty M , Hartsfield PM , Balasubramaniyan V , Chalishazar MD , Moran C , Kalhor N , Stewart J , Tran H , Swisher SG , Roth JA , Zhang J , de Groot J , Glisson B , Oliver TG , Heymach JV , Wistuba I , Robson P , Wang J , Byers LA . Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer. Nat Cancer 2020; 1(4): 423–436

[5] Chan JM , Quintanal-Villalonga Á , Gao VR , Xie Y , Allaj V , Chaudhary O , Masilionis I , Egger J , Chow A , Walle T , Mattar M , Yarlagadda DVK , Wang JL , Uddin F , Offin M , Ciampricotti M , Qeriqi B , Bahr A , de Stanchina E , Bhanot UK , Lai WV , Bott MJ , Jones DR , Ruiz A , Baine MK , Li Y , Rekhtman N , Poirier JT , Nawy T , Sen T , Mazutis L , Hollmann TJ , Pe’er D , Rudin CM . Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer. Cancer Cell 2021; 39(11): 1479–1496.e18

[6] Rudin CM , Brambilla E , Faivre-Finn C , Sage J . Small-cell lung cancer. Nat Rev Dis Primers 2021; 7(1): 3

[7] Chen Y , Li H , Fan Y . Shaping the tumor immune microenvironment of SCLC: Mechanisms, and opportunities for immunotherapy. Cancer Treat Rev 2023; 120: 102606

[8] Kong S , Zhang J , Wang L , Li W , Guo H , Weng Q , He Q , Lou H , Ding L , Yang B . Mechanisms of low MHC I expression and strategies for targeting MHC I with small molecules in cancer immunotherapy. Cancer Lett 2024; 611: 217432

[9] Fridman WH , Meylan M , Petitprez F , Sun CM , Italiano A , Sautès-Fridman C . B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome. Nat Rev Clin Oncol 2022; 19(7): 441–457

[10] Romero D . B cells and TLSs facilitate a response to ICI. Nat Rev Clin Oncol 2020; 17(4): 195

[11] Nabet BY , Hamidi H , Lee MC , Banchereau R , Morris S , Adler L , Gayevskiy V , Elhossiny AM , Srivastava MK , Patil NS , Smith KA , Jesudason R , Chan C , Chang PS , Fernandez M , Rost S , McGinnis LM , Koeppen H , Gay CM , Minna JD , Heymach JV , Chan JM , Rudin CM , Byers LA , Liu SV , Reck M , Shames DS . Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade. Cancer Cell 2024; 42(3): 429–443.e4

[12] Serrels A , Lund T , Serrels B , Byron A , McPherson RC , von Kriegsheim A , Gómez-Cuadrado L , Canel M , Muir M , Ring JE , Maniati E , Sims AH , Pachter JA , Brunton VG , Gilbert N , Anderton SM , Nibbs RJB , Frame MC . Nuclear FAK controls chemokine transcription, Tregs, and evasion of anti-tumor immunity. Cell 2015; 163(1): 160–173

[13] Lu S , Yu Y , Zhou J , Li X , Goto K , Min X , Nishino K , Cui J , Wu L , Sakakibara J , Shu Y , Dong X , Li L , Yoneshima Y , Zhou C , Li X , Zhang Y , Huang D , Zang A , Zhang W , Wang X , Zhang L , Bai C , Fang J , Cao L , Zhao Y , Yu Y , Shi M , Zhong D , Li F , Duanmu W , Wang Y . Long-term follow-up results from the GLORY study: phase II study of gumarontinib in East Asian patients with MET exon 14 skipping mutated non-small cell lung cancer. Transl Lung Cancer Res 2025; 14(9): 3924–3938

[14] Paschalis A , Sharp A , Welti JC , Neeb A , Raj GV , Luo J , Plymate SR , de Bono JS . Alternative splicing in prostate cancer. Nat Rev Clin Oncol 2018; 15(11): 663–675

[15] Papavassiliou KA , Sofianidi AA , Gogou VA , Anagnostopoulos N , Papavassiliou AG . P53 and RB aberrations in small cell lung cancer (SCLC): from molecular mechanisms to therapeutic modulation. Int J Mol Sci 2024; 25(5): 2479

[16] Zhou G . Tobacco, air pollution, environmental carcinogenesis, and thoughts on conquering strategies of lung cancer. Cancer Biol Med 2019; 16(4): 700–713

RIGHTS & PERMISSIONS

Higher Education Press